BRIEF — Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes

Sept 24 (Reuters) — Viking Therapeutics, Inc.: Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes Viking Therapeutics, - Offering Size Increased To $275 Million Common Stock And $225 Million Notes Source text:... Further company coverage: VKTX.O (Reuters.Briefs@thomsonreuters.com;)